Uncategorized

TerrAscend Receives Conditional Approval to List on the TSX

North American cannabis operator TerrAscend Corp. has announced that it has received conditional approval from the Toronto Stock Exchange (TSX) to list its common shares on the TSX.

North American cannabis operator TerrAscend Corp. has announced that it has received conditional approval from the Toronto Stock Exchange (TSX) to list its common shares on the TSX.

Final approval of the TSX Listing is subject to the company meeting certain customary conditions required by the exchange. TerrAscend Corp. will issue a press release once the TSX confirms the date that trading will commence on the exchange.

Executive Chairman of TerrAscend, Jason Wild, said: “I would like to express my sincere appreciation to the teams at the TSX, TerrAscend and Cassels for working so hard to get us to this point.

READ MORE: Canadian Cannabis Sales Beat Estimates Growing 1.3% in April

“I speak for everyone at TerrAscend when I say we are honored to be in the position to blaze this trail for the industry.

“We have an exciting future ahead of us and we can’t wait to share the TerrAscend story with the larger audience of participants that this listing brings.”

In connection with the TSX Listing, TerrAscend Corp. has submitted a request to voluntarily delist its Common Shares from the Canadian Securities Exchange (CSE). The CSE delisting is expected to be effective on or shortly after the date the Common Shares commence trading on the TSX.

Topicsterrascendtoronto stock exchangeTSE

Stephanie Price

Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".

More from Stephanie

Spotted an error, or have a tip? Contact the newsroom.

Up next · Uncategorized

What’s On the Agenda for Business of Cannabis: New York 2025?

Ben Stevens · 14 October 2025

More